Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths

New England Journal of Medicine

Volumn 366, Issue 8, 2012, Pages 687-696

  Zauber, Ann G ^a   Winawer, Sidney J ^a   O'Brien, Michael J ^c   Lansdorp Vogelaar, Iris ^d   Van Ballegooijen, Marjolein ^d   Hankey, Benjamin F ^e   Shi, Weiji ^a   Bond, John H ^f   Schapiro, Melvin ^g   Panish, Joel F ^h   Stewart, Edward T ⁱ   Waye, Jerome D ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e CANSTAT   (United States)

^f VA MEDICAL CENTER   (United States)

^g Valley Presbyterian Hospital   (United States)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; COHORT ANALYSIS; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPIC POLYPECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84857392643     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1100370     Document Type: Article

References (54)

1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
3. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71. [Erratum, N Engl J Med 1993;328:1365-71.] (Pubitemid 23131388)
5. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81. (Pubitemid 24015040)
6. Miller FG, Joffe S. Equipoise and the dilemma of randomized clinical trials. N Engl J Med 2011;364:476-80.
7. O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study: patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371-9. (Pubitemid 20037919)
8. Winawer SJ, Zauber AG, O'Brien MJ, et al. The National Polyp Study: design, methods, and characteristics of patients with newly diagnosed polyps. Cancer 1992;70:1236-45.
9. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901-6. (Pubitemid 23086641)
10. Winawer S, O'Brien M. Management of malignant polyps. In: Waye JD, Rex DK, Williams CB, eds. Colonoscopy: principles and practice. 2nd ed. Hoboken, NJ: Wiley-Blackwell, 2009:401-11.
11. Olson SH, Layne TM, Simon JA, et al. Studying cancer in minorities: a look at the numbers. Cancer 2011;117:2762-9.
12. Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol 1994;47:1451-61.
13. Gyrd-Hansen D, Søgaard J, Kronborg O. Analysis of screening data: colorectal cancer. Int J Epidemiol 1997;26:1172-81. (Pubitemid 28010434)
14. Vogelaar I, van Ballegooijen M, Schrag D, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006;107:1624-33. (Pubitemid 44546924)
15. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
16. Jouve JL, Remontet L, Dancourt V, et al. Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer 2001;84:1477-81. (Pubitemid 32579339)
17. Launoy G, Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 1997;73:220-4. (Pubitemid 27448822)
18. Prevost TC, Launoy G, Duffy SW, Chen HH. Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. Am J Epidemiol 1998;148:609-19. (Pubitemid 128471709)
19. Surveillance, Epidemiology, and End Results (SEER) Program home page (http://www.seer.cancer.gov).
20. National Center for Health Statistics home page (http://www.cdc.gov/nchs) .
21. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003;27:65-81. (Pubitemid 36014900)
22. National Death Index. Atlanta: Centers for Disease Control and Prevention, 2011 (http://www.cdc.gov/nchs/ndi.htm).
23. Breslow NE, Day NE. Statistical methods in cancer research. Lyon, France: International Agency for Research on Cancer, 1987.
24. Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS. Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. J Clin Epidemiol 1999;52:447-52. (Pubitemid 29305350)
25. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-8. [Erratum, N Engl J Med 2000;343:1204.] (Pubitemid 30489212)
26. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-8. (Pubitemid 40664307)
27. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72. (Pubitemid 44664644)
28. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-85. (Pubitemid 47494453)
29. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-24. [Erratum, N Engl J Med 2009;361:2004.]
30. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006;295:2366-73. (Pubitemid 43788104)
31. Brenner H, Haug U, Arndt V, Stegmaier C, Altenhofen L, Hoffmeister M. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 2010;138:870-6.
32. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
33. Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med 2009;150:50-2.
34. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128-37.
35. Sandler RS. Colonoscopy and colorectal cancer mortality: strong beliefs or strong facts? Am J Gastroenterol 2010;105:1633-5.
36. Neugut AI, Lebwohl B. Colonoscopy vs sigmoidoscopy screening: getting it right. JAMA 2010;304:461-2.
37. Jørgensen OD, Kronborg O, Fenger C, Rasmussen M. Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas). Acta Oncol 2007;46:355-60. (Pubitemid 46625038)
38. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770-5.
39. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22-30.
40. Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97:1296-308. (Pubitemid 34664769)
41. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006;101:873-85.
42. Lieberman D. A call to action - measuring the quality of colonoscopy. N Engl J Med 2006;355:2588-9. (Pubitemid 44917508)
43. Atkin W, Rogers P, Cardwell C, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 2004;126:1247-56. (Pubitemid 38552789)
44. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
45. Rabeneck L, Paszat LF, Saskin R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol 2010;8:275-9.
46. Bretthauer M. The capsule and colorectal-cancer screening - the crux of the matter. N Engl J Med 2009;361:300-1.
47. Robertson DJ, Greenberg E, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41. (Pubitemid 41002040)
48. Zauber AG, Winawer SJ. High-quality colonoscopies must be an integral part of screening and surveillance programs. Gastroenterology 2006;130:620-1. (Pubitemid 43202070)
49. Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009;150:849-57.
50. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 2008;134:21-8. (Pubitemid 350309311)
51. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007;369:1603-13. (Pubitemid 46710123)
52. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-50.
53. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.
54. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85. (Pubitemid 43668826)